BAAM
HALO icon

Baker Avenue Asset Management’s Halozyme HALO Stock Holding History

Baker Avenue Asset Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-7
Closed -$267 – 834
2023
Q3 		$267 Hold
7
– – ﹤0.01% 1575
2023
Q2 		$252 Buy
+7
New +$239 ﹤0.01% 1542

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Baker Avenue Asset Management's HALO Position: Q4 2023 in Review

Baker Avenue Asset Management sold out of Halozyme (HALO) in Q4 2023, closing a stake of 7 shares — an estimated $267 sold.

Baker Avenue Asset Management first reported a position in HALO in Q2 2023 and held it in 2 quarters. The position peaked at $267 in Q3 2023. 410 funds tracked by Wall St. Rank hold HALO as of Q4 2023.

  • Baker Avenue Asset Management reported no remaining Halozyme position as of Q4 2023 after selling out during the quarter.
  • Baker Avenue Asset Management sold 7 Halozyme shares in Q4 2023, an estimated $267.
  • Baker Avenue Asset Management first reported a position in Halozyme in Q2 2023 and held it in 2 quarters.
  • Baker Avenue Asset Management's Halozyme position peaked at $267 in Q3 2023.
  • 410 funds tracked by Wall St. Rank held Halozyme as of Q4 2023.

Based on Baker Avenue Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.